Home/Hedge Fund Intelligence/Mineralys Therapeutics, Inc.
Nasdaq: MLYSStockForm 13F30 Jun 2026

Hedge funds that hold Mineralys Therapeutics, Inc. Nasdaq: MLYS

CUSIP 603170101 · who reports it, how much, and how much it matters to them

37 of the 720 hedge fund managers we track reported shares of Mineralys Therapeutics, Inc. (Nasdaq: MLYS) on Form 13F for 30 June 2026. Between them they reported USD 570m. The largest position belongs to Ra Capital Management, at USD 208m. The manager with the most riding on it is Sphera Funds Management, where it is 5.2% of the reported book.

Managers reporting it37of 720 we track
Value they reportUSD 570mshares only, 30 Jun 2026
Funds they run520with a file on PPLI.com
Largest positionUSD 208mRa Capital Management
Typical weight0.1%median share of a manager's book
Heaviest weight5.2%Sphera Funds Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

37 managers, USD 570m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Mineralys Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Ra Capital Management1 fund on PPLI.comUSD 208m1.8%
2Orbimed Advisors1 fund on PPLI.comUSD 57m1.1%
3Armistice Capital1 fund on PPLI.comUSD 47m0.6%
4Sphera Funds Management1 fund on PPLI.comUSD 40m5.2%
5Polar Capital LLP26 funds on PPLI.comUSD 38m0.1%
6Millennium Management6 funds on PPLI.comUSD 33m0.0%
7Logos Global Management1 fund on PPLI.comUSD 28m1.2%
8Tudor Investment Corporation10 funds on PPLI.comUSD 20m0.0%
9Rock Springs Capital Management2 funds on PPLI.comUSD 13m0.6%
10Citadel Advisors32 funds on PPLI.comUSD 13m0.0%
11Renaissance Technologies13 funds on PPLI.comUSD 10m0.0%
12D. E. Shaw & Co.15 funds on PPLI.comUSD 9.5m0.0%
13Eversept Partners3 funds on PPLI.comUSD 8.4m0.4%
14Suvretta Capital Management4 funds on PPLI.comUSD 4.7m0.1%
15Two Sigma Investments35 funds on PPLI.comUSD 4.4m0.0%
16Brevan Howard Capital Management39 funds on PPLI.comUSD 4.1m0.0%
17Burkehill Global Management5 funds on PPLI.comUSD 4m0.1%
18Boothbay Fund Management2 funds on PPLI.comUSD 4m0.1%
19Artia Global Partners1 fund on PPLI.comUSD 3.7m0.7%
2022NW1 fund on PPLI.comUSD 3.1m2.9%
21Exoduspoint Capital Management7 funds on PPLI.comUSD 2.7m0.0%
22Schonfeld Strategic Advisors30 funds on PPLI.comUSD 2.6m0.0%
23Squarepoint Ops7 funds on PPLI.comUSD 2.3m0.0%
24HighVista Strategies27 funds on PPLI.comUSD 2.3m0.5%
25PFM Health Sciences3 funds on PPLI.comUSD 1.7m0.1%
26Dafna Capital Management6 funds on PPLI.comUSD 1.2m0.2%
27Verition Fund Management3 funds on PPLI.comUSD 937,0000.0%
28Magnetar Financial93 funds on PPLI.comUSD 818,0000.0%
29Greenland Capital Management1 fund on PPLI.comUSD 809,0000.1%
30Marshall Wace LLP84 funds on PPLI.comUSD 486,0000.0%
31Capital Fund Management S.A.12 funds on PPLI.comUSD 428,0000.0%
32Persistent Asset Partners10 funds on PPLI.comUSD 389,0000.1%
33The Quarry1 fund on PPLI.comUSD 340,0000.0%
34Lion Point Capital1 fund on PPLI.comUSD 283,0001.4%
35Walleye Capital8 funds on PPLI.comUSD 271,0000.0%
36Capstone Investment Advisors25 funds on PPLI.comUSD 226,0000.0%
37Aquatic Capital Management3 funds on PPLI.comUSD 141,0000.0%
Next: where it matters most
Where it matters most

For Sphera Funds Management it is 5.2% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Sphera Funds ManagementUSD 40m5.2%
222NWUSD 3.1m2.9%
3Ra Capital ManagementUSD 208m1.8%
4Lion Point CapitalUSD 283,0001.4%
5Logos Global ManagementUSD 28m1.2%
6Orbimed AdvisorsUSD 57m1.1%
7Artia Global PartnersUSD 3.7m0.7%
8Rock Springs Capital ManagementUSD 13m0.6%
9Armistice CapitalUSD 47m0.6%
10HighVista StrategiesUSD 2.3m0.5%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Mineralys Therapeutics, Inc.

What is the ticker symbol of Mineralys Therapeutics, Inc.?

Mineralys Therapeutics, Inc. trades under the symbol MLYS on the Nasdaq. Its CUSIP, the code used on Form 13F, is 603170101.

Which hedge funds own Mineralys Therapeutics, Inc. (Nasdaq: MLYS)?

37 of the 720 hedge fund managers PPLI.com tracks reported Mineralys Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 208m), Orbimed Advisors (USD 57m), Armistice Capital (USD 47m), Sphera Funds Management (USD 40m) and Polar Capital LLP (USD 38m).

How many hedge funds hold Mineralys Therapeutics, Inc.?

37 managers in our coverage reported it, and between them they run 520 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Mineralys Therapeutics, Inc.?

Sphera Funds Management, where the position was 5.2% of the reported 13F book at 30 June 2026.

Does this show who is short Mineralys Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Mineralys Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.